ANN ARBOR, Mich. (AP) — ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Thursday reported a loss of $29.5 million in its third quarter.

The Ann Arbor, Michigan-based company said it had a loss of 15 cents per share.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The biopharmaceutical company posted revenue of $51.6 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $55.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR